Ventilator-associated pneumonia: pathobiological heterogeneity and diagnostic challenges
Abstract Ventilator-associated pneumonia (VAP) affects up to 20% of critically ill patients and induces significant antibiotic prescription pressure, accounting for half of all antibiotic use in the ICU. VAP significantly increases hospital length of stay and healthcare costs yet is also associated with long-term morbidity and mortality. The diagnosis of VAP continues to present challenges […]
Ventilator-associated pneumonia: pathobiological heterogeneity and diagnostic challenges Read Post »